OPK CEO continues to buy the stock as he has done throughout 2020.
High short interest.
Indicators tuning bullish as the reverse.
Alert set for a break above $3.85
Potential targets -to consider,
100MA
Downtrend.
Horizontal resistance as per chart.
OPK seems to be doing good, and analysts are saying that it is a buy (according to MarketWatch)
You can kinda see that it is following an upward trend line. There is also strong support at $3.45
The price is also forming a big triangle.
RSI is low and there is plenty of volume.
I'm going to get in at $3.48 with my stop loss at $3.24 (6.9%). I'm hoping for it to...
OPKO came out of its slump in late September. It had been oversold prior and needed over month to build up momentum again. It went over two week rally of roughly 4-5% gain everyday.
The rally stopped the down trend line from mid summer.
Interesting to note the Oct 12 was the day of the 10 DMA crossed the 50 DMA. The PA immediately want lower to test the 50...
Stimulus seems to be leaving the spotlight. Waiting to see if it starts to shift back to Covid testing and treatment. Once I see Covid penny stocks pumping, I will jump in on this and wait for the inevitable pump!
OPK is the official covid test of the NFL, which was announced mid/early July. I think now some of that FOMO has been shaken out off that news. Whether or not there is a wave 2 (don't science at me please) people will continue to be tested, and often if playing pro sports. If OPK has a legit test (the NFL thinks so) then this could be around for a while. Areas of...
Fallen angel on hourly chart. Possible entry above 4.20. Stop signal 3.77 based off of hourly support. First target 5.23. Second target 5.83. Third Target momentum.
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico,...
